Position
SYNTAX RESEARCH, INC. in Eli Lilly & Co
Back to the book · All holders of LLY
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$21.7K$1,074.69 → $919.77
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 140 | $150.5K | — | — | — | 0.1% |
| Q1 2026 | 140 | $128.8K | $919.77 | −$21.7K | $0 | 0.1% |